| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.24 | 0.1 |